Global Erythropoietin Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Erythropoietin Market
The global Erythropoietin market size is projected to reach US$ 12840 million by 2027, from US$ 8657 million in 2020, at a CAGR of 5.8% during 2021-2027.
Global Erythropoietin Scope and Segment
The global Erythropoietin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erythropoietin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
By the end users/application, this report covers the following segments
Anemia
Kidney Disorders
Others
Competitive Landscape:
The report provides a list of all the key players in the Erythropoietin market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Erythropoietin key manufacturers in this market include:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences

TABLE OF CONTENT

1 Erythropoietin Market Overview
1.1 Erythropoietin Product Overview
1.2 Erythropoietin Market Segment by Type
1.2.1 Epoetin-alfa
1.2.2 Epoetin-beta
1.2.3 Darbepoetin-alfa
1.2.4 Others
1.3 Global Erythropoietin Market Size by Type
1.3.1 Global Erythropoietin Market Size Overview by Type (2016-2027)
1.3.2 Global Erythropoietin Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Erythropoietin Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Erythropoietin Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Erythropoietin Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Erythropoietin Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Erythropoietin Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Erythropoietin Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Erythropoietin Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Erythropoietin Sales Breakdown by Type (2016-2030)
1.4.2 Europe Erythropoietin Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Erythropoietin Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Erythropoietin Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Erythropoietin Sales Breakdown by Type (2016-2030)

2 Global Erythropoietin Market Competition by Company
2.1 Global Top Players by Erythropoietin Sales (2016-2030)
2.2 Global Top Players by Erythropoietin Revenue (2016-2030)
2.3 Global Top Players Erythropoietin Price (2016-2030)
2.4 Global Top Manufacturers Erythropoietin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Erythropoietin Market Competitive Situation and Trends
2.5.1 Erythropoietin Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Erythropoietin Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Erythropoietin as of 2020)
2.7 Date of Key Manufacturers Enter into Erythropoietin Market
2.8 Key Manufacturers Erythropoietin Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Erythropoietin Status and Outlook by Region
3.1 Global Erythropoietin Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Erythropoietin Historic Market Size by Region
3.2.1 Global Erythropoietin Sales in Volume by Region (2016-2030)
3.2.2 Global Erythropoietin Sales in Value by Region (2016-2030)
3.2.3 Global Erythropoietin Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Erythropoietin Forecasted Market Size by Region
3.3.1 Global Erythropoietin Sales in Volume by Region (2022-2027)
3.3.2 Global Erythropoietin Sales in Value by Region (2022-2027)
3.3.3 Global Erythropoietin Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Erythropoietin by Application
4.1 Erythropoietin Market Segment by Application
4.1.1 Anemia
4.1.2 Kidney Disorders
4.1.3 Others
4.2 Global Erythropoietin Market Size by Application
4.2.1 Global Erythropoietin Market Size Overview by Application (2016-2027)
4.2.2 Global Erythropoietin Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Erythropoietin Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Erythropoietin Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Erythropoietin Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Erythropoietin Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Erythropoietin Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Erythropoietin Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Erythropoietin Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Erythropoietin Sales Breakdown by Application (2016-2030)
4.3.2 Europe Erythropoietin Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Erythropoietin Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Erythropoietin Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Erythropoietin Sales Breakdown by Application (2016-2030)

5 North America Erythropoietin by Country
5.1 North America Erythropoietin Historic Market Size by Country
5.1.1 North America Erythropoietin Sales in Volume by Country (2016-2030)
5.1.2 North America Erythropoietin Sales in Value by Country (2016-2030)
5.2 North America Erythropoietin Forecasted Market Size by Country
5.2.1 North America Erythropoietin Sales in Volume by Country (2022-2027)
5.2.2 North America Erythropoietin Sales in Value by Country (2022-2027)

6 Europe Erythropoietin by Country
6.1 Europe Erythropoietin Historic Market Size by Country
6.1.1 Europe Erythropoietin Sales in Volume by Country (2016-2030)
6.1.2 Europe Erythropoietin Sales in Value by Country (2016-2030)
6.2 Europe Erythropoietin Forecasted Market Size by Country
6.2.1 Europe Erythropoietin Sales in Volume by Country (2022-2027)
6.2.2 Europe Erythropoietin Sales in Value by Country (2022-2027)

7 Asia-Pacific Erythropoietin by Region
7.1 Asia-Pacific Erythropoietin Historic Market Size by Region
7.1.1 Asia-Pacific Erythropoietin Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Erythropoietin Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Erythropoietin Forecasted Market Size by Region
7.2.1 Asia-Pacific Erythropoietin Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Erythropoietin Sales in Value by Region (2022-2027)

8 Latin America Erythropoietin by Country
8.1 Latin America Erythropoietin Historic Market Size by Country
8.1.1 Latin America Erythropoietin Sales in Volume by Country (2016-2030)
8.1.2 Latin America Erythropoietin Sales in Value by Country (2016-2030)
8.2 Latin America Erythropoietin Forecasted Market Size by Country
8.2.1 Latin America Erythropoietin Sales in Volume by Country (2022-2027)
8.2.2 Latin America Erythropoietin Sales in Value by Country (2022-2027)

9 Middle East and Africa Erythropoietin by Country
9.1 Middle East and Africa Erythropoietin Historic Market Size by Country
9.1.1 Middle East and Africa Erythropoietin Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Erythropoietin Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Erythropoietin Forecasted Market Size by Country
9.2.1 Middle East and Africa Erythropoietin Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Erythropoietin Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Erythropoietin Business
10.1 Amgen
10.1.1 Amgen Corporation Information
10.1.2 Amgen Introduction and Business Overview
10.1.3 Amgen Erythropoietin Sales, Revenue and Gross Margin (2016-2030)
10.1.4 Amgen Erythropoietin Products Offered
10.1.5 Amgen Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Corporation Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Erythropoietin Sales, Revenue and Gross Margin (2016-2030)
10.2.4 Johnson & Johnson Erythropoietin Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Roche
10.3.1 Roche Corporation Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Erythropoietin Sales, Revenue and Gross Margin (2016-2030)
10.3.4 Roche Erythropoietin Products Offered
10.3.5 Roche Recent Development
10.4 Galenica
10.4.1 Galenica Corporation Information
10.4.2 Galenica Introduction and Business Overview
10.4.3 Galenica Erythropoietin Sales, Revenue and Gross Margin (2016-2030)
10.4.4 Galenica Erythropoietin Products Offered
10.4.5 Galenica Recent Development
10.5 Emcure
10.5.1 Emcure Corporation Information
10.5.2 Emcure Introduction and Business Overview
10.5.3 Emcure Erythropoietin Sales, Revenue and Gross Margin (2016-2030)
10.5.4 Emcure Erythropoietin Products Offered
10.5.5 Emcure Recent Development
10.6 Kyowa Hakko Kirin
10.6.1 Kyowa Hakko Kirin Corporation Information
10.6.2 Kyowa Hakko Kirin Introduction and Business Overview
10.6.3 Kyowa Hakko Kirin Erythropoietin Sales, Revenue and Gross Margin (2016-2030)
10.6.4 Kyowa Hakko Kirin Erythropoietin Products Offered
10.6.5 Kyowa Hakko Kirin Recent Development
10.7 3SBio
10.7.1 3SBio Corporation Information
10.7.2 3SBio Introduction and Business Overview
10.7.3 3SBio Erythropoietin Sales, Revenue and Gross Margin (2016-2030)
10.7.4 3SBio Erythropoietin Products Offered
10.7.5 3SBio Recent Development
10.8 Biocon
10.8.1 Biocon Corporation Information
10.8.2 Biocon Introduction and Business Overview
10.8.3 Biocon Erythropoietin Sales, Revenue and Gross Margin (2016-2030)
10.8.4 Biocon Erythropoietin Products Offered
10.8.5 Biocon Recent Development
10.9 LG Life Sciences
10.9.1 LG Life Sciences Corporation Information
10.9.2 LG Life Sciences Introduction and Business Overview
10.9.3 LG Life Sciences Erythropoietin Sales, Revenue and Gross Margin (2016-2030)
10.9.4 LG Life Sciences Erythropoietin Products Offered
10.9.5 LG Life Sciences Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Erythropoietin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Erythropoietin Industrial Chain Analysis
11.4 Erythropoietin Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Erythropoietin Distributors
12.3 Erythropoietin Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample